Clinical Research Directory
Browse clinical research sites, groups, and studies.
Fetal Brain Care: Therapies for Brain Neurodevelopment in Fetal Growth Restriction
Sponsor: Institut d'Investigacions Biomèdiques August Pi i Sunyer
Summary
Singleton pregnancies being diagnosed of fetal growth restriction from 24 to 32.6 weeks of gestation will be randomized to two equally sized groups: maternal oral supplementation with Lactoferrin and DHA (Docosahexaenoic acid) or placebo.
Key Details
Gender
FEMALE
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
304
Start Date
2023-01-18
Completion Date
2026-12
Last Updated
2024-03-18
Healthy Volunteers
No
Interventions
Lactoferrin and DHA
The intervention consists in the maternal oral administration of 1000mg of Lactoferrin and 1000mg of DHA daily
Placebo
Product with the same physical appearance and taste as the main intervention but without therapeutic effect
Locations (6)
Hospital Clínic de Barcelona
Barcelona, Spain
Hospital de la Santa Creu i Sant Pau
Barcelona, Spain
Hospital del Mar
Barcelona, Spain
Hospital Dexeus-Quirón
Barcelona, Spain
Hospital Sant Joan de Déu
Esplugues de Llobregat, Spain
Hospital General del Hospitalet
L'Hospitalet de Llobregat, Spain